Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 USD | +1.76% | -1.60% | +74.15% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.15% | 257M | |
+30.12% | 48.16B | |
-0.82% | 41.73B | |
+42.66% | 41.03B | |
-5.26% | 28.77B | |
+10.15% | 25.59B | |
-22.65% | 18.96B | |
+9.12% | 12.92B | |
+29.25% | 12.03B | |
-1.98% | 11.77B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- SVB Downgrades Design Therapeutics to Market Perform From Outperform, Cuts Price Target to $6 From $22